CTRI/2016/03/006745
Recruiting
Phase 2
A prospective, open label, pilot study to evaluate the role of Sucralfate in the management of pressure ulcers.
Internal FLUID Grant Christian Medical College Vellore0 sites30 target enrollmentTBD
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Internal FLUID Grant Christian Medical College Vellore
- Enrollment
- 30
- Status
- Recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Patients with Grade 3 pressure ulcer as per NPUAP
- •guidelines.
- •2\. Patients aged between 18\-60 years, both male \& female, any ethnicity.
- •3\. Patients who are able to give valid consent.
Exclusion Criteria
- •1\. Wounds with necrotic tissue.
- •2\. Patients with anemia. (Hb \< 8gm%)
- •3\. Patients with hypoalbuminemia. (albumin \< 2gm%)
- •4\. Patient with any known renal disease will be excluded.
- •5\. H/O diabetes, connective tissue disorder, malignancy,psychiatric disorder and any other major systemic illness.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
A prospective study to assess the effect of adalimumab on cardiovascular biomarkers in participants with severe chronic plaque psoriasisChronic plaque psoriasisSkin - Dermatological conditionsInflammatory and Immune System - Other inflammatory or immune system disordersACTRN12613000419763Dr Anna Braue15
Active, not recruiting
Not Applicable
A study of Ayurvedic Arsenic compound (Somal) in treatment of solid tumors.Health Condition 1: C00-D49- NeoplasmsCTRI/2018/04/013086Rasayani Biologics Pvt Ltd
Recruiting
Phase 3
A Prospective, Open-label Pilot Study to Evaluate Effector mechanisms of Hyperbaric Oxygen Therapy in Patients with Moderate-to-Severe Ulcerative Colitis: The PARADOX studyIBDulcerative colitis10017969NL-OMON52110Academisch Medisch Centrum24
Active, not recruiting
Not Applicable
An open label, randomized pilot study to evaluate diagnostic treatment interruption in HIV-positive children under a stable antiretroviral therapy in order to save medication and reduce possible side effects.B24Unspecified human immunodeficiency virus [HIV] diseaseDRKS00000473J.W. Goethe UniversitätZentrum für Kinder- und Jugendmedizin1
Completed
Not Applicable
An open label, cross over pilot study to evaluate the effect of a single dose of TW001 on the oxidative stress and pharmacokinetics with and without food in patients with amyotrophic lateral sclerosisNL-OMON42324Treeway B.V.8